If Walgreens Boots Alliance follows through with a sale to private equity, the company might join other healthcare deals ...

Pharmaceutical retailer Walgreens explores potential acquisition deal with private equity firm Sycamore Partners.

Albertsons, in its own announcement terminating the agreement on Wednesday, also said it had authorized a $2 billion stock buyback and hiked its quarterly cash dividend by 25%. The chain's biggest ...

THE future of Boots has been plunged into uncertainty while a buyout fund negotiates with its US owner. Pharmacy giant Walgreens Boots Alliance, which bought Boots in 2014, is understood to be in ...

Walgreens Boots Alliance is considering selling the company to a private equity firm — a move that would take the publicly traded company private, according to a Wall Street Journal report.

US stocks mostly rose on Wednesday with the Nasdaq jumping to another all-time high on the back of strong gains in the tech sector, though the Dow continued its recent downward path.

Broadcom stock approached a buy point following news reports that the fabless chipmaker is designing an AI server chip for Apple.

Walgreens has struggled lately due to declining prescription reimbursements and rising competition from Amazon and other ...

Walgreens surges amid buyout rumors with Sycamore Partners, but doubts remain on deal feasibility and long-term prospects.

Walgreens Boots Alliance is reportedly considering selling itself to private equity firm Sycamore Partners and becoming private, The Wall Street Journal reported Dec. 10. Here are five things to know: ...

Walgreens Boots Alliance Inc. (Nasdaq: WBA) is reportedly in talks to sell itself to the PE firm Sycamore Partners. The move would take the retailer ...

Following the report, shares of the pharmacy giant jumped 18%, the largest one-day boost in Walgreens' history.